Doreen Nazeih Younan

Doreen Nazeih Younan

Auto-generated profile, based on publicly available information

Doreen Nazeih Younan

Clinical and Chemical Pathology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
MRMohamed Mostafa Rizk
Mohamed Mostafa Rizk
OSOla Atef Sharaki
Ola Atef Sharaki
MMMahmoud Elsayed Meleis
Mahmoud Elsayed Meleis
DYDoreen Nazeih Younan
Doreen Nazeih Younan
AEAlyaa Abdallah Elkial
Alyaa Abdallah Elkial
PMPacinte Moez
Pacinte Moez
Background: Ovarian cancer is the seventh most common cancer in females with the highest mortality rate of all gynecological cancers due to its late discovery and ambiguous symptoms. Thus, there is a need for new promising strategies to diagnose ovarian cancer. We aimed at finding a characteristic plasma proteome pattern that could be used for the detection of epithelial ovarian cancer, in comparison with benign ovarian masses and healthy controls. We also aimed at differentiating between profiling of plasma proteins in early and advanced stages of ovarian cancer and between serous and non-serous histopathological types. Methods: The combination of MagSi-proteomics C8 beads, Ultraflextreme MALDI-TOF and ClinPro Tools software was used to compare the plasma protein spectra from 50 patients with epithelial ovarian cancer, 20 patients with benign ovarian masses and 50 age matched healthy females. Results: A plasma proteome profile of 21 peaks differentiated patients with epithelial ovarian cancer from healthy controls with a sensitivity of 73 % and a specificity of 82.8% upon external validation, while a 5-peak profile differentiated patients with epithelial ovarian cancer from patients with benign ovarian masses with a sensitivity of 81% and a specificity of 73.7%. A 20 peak profile was generated to discriminate between early and late stages of the disease with 88.3% recognition capability and 70% cross validation. Conclusion: MALDI-TOF proteomic profiling represents a promising potential tool for diagnosing epithelial ovarian cancer, discriminating between early and advanced stages and between serous and non- serous types. Asian Pacific Journal of Cancer Prevention (APJCP)


27 February 2014 in Andrologia
Verified
Journal Article
Open access
PDF file
DYD. Younan
D. Younan
ASA. Sorour
A. Sorour
RGR. Genedy
R. Genedy
Chromosome anomalies were suggested to be more frequent in infertile males so our case-control study aimed at evaluating the incidence of spermatic aneuploidies in forty males with severe oligoasthenoteratozoospermia (OAT) and comparing it with that in another forty males having normal semen parameters. Semen samples were collected and analysed in the Clinical Pathology Department according to criteria of the World Health Organization (WHO laboratory manual for the examination and processing of human semen, 2010, WHO Press). Fluorescence in situ hybridisation (FISH) was performed on decondensed spermatozoa from fresh semen ejaculates, using dual coloured chromosome-specific DNA probes labelled with fluorochromes to study sperm aneuploidies in chromosomes 13, 21, X and Y. There was no statistical significant difference between cases and controls regarding disomy frequencies for chromosomes 13, 21 or both combined. However, 13, 21 diploidy frequency was significantly higher among OAT cases. Regarding chromosomes X and Y, both cases and controls showed similar results for disomy/diploidy frequency for both chromosomes; however, there was a statistical significant increase in YY disomy/diploidy frequency among OAT patients. X chromosome-bearing spermatozoa were found to be significantly higher among controls. Patients with severe OAT have a higher total sperm aneuploidy rate, regarding chromosomes 13, 21, X and Y but without a statistical significant difference.

1 July 2020 in Egyptian Journal of Medical Human Genetics
Verified
Journal Article
Open access
PDF file
MRMohamed Mostafa Mohamed Ahmed Rizk
Mohamed Mostafa Mohamed Ahmed Rizk
SHSuzan Mohamed Farouk Helal
Suzan Mohamed Farouk Helal
AGAhmed Youssef Shaaban Gad
Ahmed Youssef Shaaban Gad
DYDoreen Nazeih Assaad Younan
Doreen Nazeih Assaad Younan
SMSalma Abd El Maguid Mohamed Ramadan Moemen
Salma Abd El Maguid Mohamed Ramadan Moemen
Lung cancer tumorigenesis is mainly due to accumulation of genetic and epigenetic events in the respiratory epithelium. Epigenetic alteration is more frequent than somatic mutation in lung cancer. CpG island methylation of homeobox-associated genes is commonly seen in most early stage tumors. This study aimed at examining the potential usefulness of DNA methylation biomarker SHOX2, in broncho-alveolar lavage, in the diagnosis of lung cancer. Broncho-alveolar lavage was obtained from 80 patients; 60 cases with lung masses (proved malignant by histopathology) and 20 age and gender matched patients with benign lung lesions (benign controls). SHOX2 methylation status was evaluated using methylation analysis by restriction endonuclease digestion and real-time PCR. SHOX2 methylation level ranged 3.90–77.16% in cases, and 3.52–7.86% in controls, (p ≤ 0.001). SHOX2 methylation levels in comparison to tissue biopsy pathology (the gold standard test) had 76.92% sensitivity, 70% specificity, 87% positive predictive value, and 53.8% negative predictive value in diagnosing lung cancer. Different methylation levels were noted in different lung pathologies, (p = 0.003), with the highest methylation levels in squamous cell carcinoma followed by adenocarcinoma and anaplastic carcinoma then lastly carcinoma in situ. SHOX2 methylation levels could differentiate different varieties of lung cancer from benign lung lesions.

1 December 2020
Verified
Journal Article
Closed access
OROssama H. Roshdy
Ossama H. Roshdy
RMRania E. Abdel Maksoud
Rania E. Abdel Maksoud
YKYasser S. El Kassar
Yasser S. El Kassar
DYDoreen N. Younan
Doreen N. Younan
RSRana R. El Sayed
Rana R. El Sayed
Routine semen analysis is a poor predictor of pregnancy rates after intra-cytoplasmic sperm injection (ICSI). There is an assumption that embryos' quality and fertilization rates could be influenced by epigenetic factors. We aimed at comparing global sperm DNA methylation level (GSDML) between normal and abnormal semen, investigating its relationship with sperm parameters and assessing its effect on ICSI outcomes; fertilization, good embryo and pregnancy rates. Ejaculates were obtained from 104 infertile and 60 fertile males undergoing ICSI at Faculty of Medicine, Alexandria, Egypt. Data was analyzed using IBM SPSS software package, 20. Inter-group differences in semen parameters were assessed by t-test. GSDML, measured by ELISA, showed significant positive correlation with sperm count, concentration and motility. It correlated positively but insignificantly with morphology and fertilization rate. High levels were significantly associated with embryos having good quality and positive pregnancy rates. GSDML could predict good embryo rate and pregnancy occurrence after ICSI.

30 March 2015 in International Cardiovascular Forum Journal
Verified
Journal Article
Open access
PDF file
DYDoreen Younan
Doreen Younan
OSOla Sharaki
Ola Sharaki
MSMohamed Sobhi
Mohamed Sobhi
EEEman Elkemary
Eman Elkemary
Background: Oxidation of low density lipoproteins is an initial step of atherogenesis that generates pro-inflammatory phospholipids, including platelet-activating factor (PAF) and its analogs. Platelet-activating factor is degraded by lipoprotein associated phospholipase A2 (Lp-PLA2), also known as platelet-activating factor-acetylhydrolase (PAF-AH), a circulating enzyme having both pro and anti-inflammatory activities. Lipoprotein associated phospholipase A2 activity has been postulated to be a risk factor for acute coronary syndrome (ACS); however, whether Lp-PLA2 has a causal or protective role is still unclear. A large number of single nucleotide polymorphisms (SNPs) that affect Lp-PLA2 mass and activity in plasma have been described. Aim: The aim of the present work is to determine the prevalence of Lp-PLA2 gene A379V single nucleotide polymorphism (SNP) in Egyptians suffering from myocardial infarction (MI) in comparison to healthy controls and to correlate this genetic variant with different cardiovascular risk factors. Methods: Lp-PLA2 gene A379V polymorphism (rs1051931) was investigated in fifty patients having MI and fifty age and sex matched healthy controls using real-time PCR. Results: The homozygous CC genotype, coding for alanine at position 379 of Lp-PLA2 protein, had the highest frequency among patients (72%) compared with controls (46%) while heterozygous CT genotype had the highest frequency among controls (46%) compared with patients (24%) with a significant difference (p=0.033). The major “C” allele had the highest frequency among patients (84%) compared with controls (69%) while the minor “T” allele, coding for valine at the same position, had the highest frequency among controls (31%) compared with patients (16%) with a significant difference (p=0.012). Conclusion: The Lp-PLA2 A379V gene polymorphism was found to be less frequent in MI patients presented with ACS than in healthy controls, suggesting that this SNP might be protective against the development of MI.